Healthcare Stocks Taking A Beating Today | MNKD, XOMA, VRX
Today is proving to be a rough day for the biotech market. In reality, it’s a tough day for the US market in general. As investors take in the fact that the Federal Reserve is planning to increase its interest rate in December, they are balancing portfolios for less risk. This, mixed with poor earnings, … Read more